Erna Roth

COMPOSITION COMPRISING A (METH)ACRYLATE COPOLYMER, AN ALKALI OR AMMONIUM SALT OF A SATURATED ALIPHATIC MONOCARBOXYLIC ACID AND SPECIFIC GLIDANTS

Pharmaceutical or neutraceutical formulation

Process for converting a solid (meth)acrylate copolymer into a dispersed form by means of a dispersing agent

COMPOSITION COMPRISING AN ANIONIC POLYMERIC MATERIAL AND THE SALT OF A SATURATED MONOCARBOXYLIC ACID HAVING 6 TO 22 CARBON ATOMS

POWDERY OR GRANULATED COMPOSITION COMPRISING A COPOLYMER, A SALT OF A FATTY MONOCARBOXYLIC ACID AND A FATTY MONOCARBOXYLIC ACID AND/OR A FATTY ALCOHOL

Powdery or granulated composition comprising a copolymer, a dicarboxylic acid and a fatty monocarboxylic acid

Partly neutralised anionic (meth) acrylate copolymer

Pharmaceutical form having a two-layer separating layer

Multiparticle pharmaceutical dosage form containing a mucoadhesively formulated peptide or protein active substances method for producing said pharmaceutical dosage form

Coating and binding agent for pharmaceutical formulations with improved storage stability

Method of producing pharmaceuticals or food supplements comprising pigmented polymer coatings

Methods for coating substrates for pharmaceutical uses with a mixture of two film-forming coating agents

Method for producing coated pharmaceuticals and food supplements with concentration gradients in the coating thereof

Granulate or powder for producing coating or binding agents for medicaments

Adhesive and binding agent for dermal or transdermal treatment systems

Coating and binding agent for oral or dermal pharmaceutical forms